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Purpose Transcatheter closure of the arterial duct using the Occlutech
PDA occluder. 
Methods and results From March 2013 to April 2015, 16 patients under-
went percutaneous arterial duct closure with the new Occlutech PDA occluder.
There were 10 females and 6 males. All patients had significant L-to-R shunt
with enlarged left ventricle.
At implantation, the mean age was 87 months (median 35 months) and
mean weight was 16±11kg (7.2 to 54kg). The procedure was realized under
local anaesthesia. Size of the duct was 2.96±0.94mm (range 1.7 to 5.5mm) on
angiography. According to Krichenko classification of PDA, ducts were: type
A (n=14), Type B (n=1) and type E (n=1). The systolic pulmonary artery pres-
sure was 43±17mmHg (range 24 to 91mmHg). Implantation succeeded in all.
Closure was performed by the standard 4/6mm occluder (n=8), the standard
6/8mm occluder (n=3), the standard 5/7mm occluder (n=3), the standard 3.5/
5mm (n=1) and the standard 8/10mm occluder (n=1) using a 6 or 7 F delivery
sheath. After implantation, trivial shunt was noticed on angiography in
12 patients, 4 had no shunt. The fluoroscopic time was 6.5±8.7 minutes and
radiation dose 6.0±4 Gycm2. After closure, femoral thrombosis was noticed in
2 patients but resolved completely under heparin therapy. On control Doppler
echocardiography (1 to 18 months), duct was closed in all patients but one
with only one month follow-up. No obstruction of the left pulmonary artery or
isthmic stenosis was noticed.
Conclusions Percutaneous closure of PDA with the new Occlutech PDA
occluder is safe and effective. The device is easy to handle and there is no
learning curve for operators using the classic Amplatzer duct occluder.
Further studies with longer follow-up are necessary to confirm these good
results. 
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Objective The main objective was to evaluate the safety and the efficacy
of balloon angioplasty of post-surgical aortic recoarctation before one year of
age. The secondary objective was to identify factors potentially associated
with a failure of the procedure. 
Method Data from children who have one or more balloon angioplasty for
aortic recoarctation before one year of age were retrospectively collected from
2006 to 2014. 
Results 14 children (17 procedures) have been included. The procedure
immediately failed in 2 patients who underwent a new surgery. All the other
12 patients still remained free of recoarctation after one procedure for 10 of
them, 2 procedures for another one and 3 procedures for the last one. Three
complications due to the procedure occurred: one iliac artery thrombosis, one
coronary embolism and one transitory stroke. These complications totally
recovered before discharge. No aortic dissection or aneurysm has been
reported. Comparing the 5 procedures which need a further intervention with
the others, we observed that a higher peak gradient measured during the cathe-
terization before (45mmHg (range 36-60) vs 32mmHg (range 10-47)) and after
the angioplasty (36mmHg (range 30-50) vs 25mmHg (range 5-50)), and a
lower ratio balloon size/transverse arch diameter (1.07 (range 0.88-1.20) vs
1.28 (range 0.94-1.82)) were associated with a failure of the procedure.
Conclusion Balloon angioplasty of aortic recoarctation before one year of
age is efficient. A lower ratio balloon size/transverse arch diameter was asso-
ciated with a higher failure of the procedure that suggests the use of bigger
balloon.
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Background Transcatheter closure of patent ductus arteriosus (PDA) is
considered as the standard treatment of PDA due to its easy technical feasi-
bility and its successful outcomes. But this procedure remains depending on
the operator experience and the cardiology center. 
Aim To evaluate the feasibility and the effectiveness of transcatheter clo-
sure of PDA Fattouma Bourguiba department, Monastir, Tunisia.
Method We carried out a retrospective study on patients who underwent
transcatheter closure of PDA in during the period of 2011-2014. Data about
symptoms, characteristics of PDA, procedure of closure and complications
were retrieved.
Results There were 23 patients, of whom 17 were females, who underwent
transcatheter closure of PDA during the study period. Median age was
5.5 years (1 months-21 years), and median body weight was 13 (3-55)kg.
Growth retardation was found in 13 patients. The diameter of PDA ranged
from 3 to 7mm with a median of 3.8mm and the dilatation of the left ventricle
was found in 9 patients. Device deployed in all patients was the Amplatzer
ductal occlude (ADO). Median fluoroscopy time was 14.6 (2.2-56) min, and
procedure time was 50 (27-145) min. Complete closure was achieved in most
patients (95.7%), whereas device migration in the pulmonary artery occurred
one patient (4.3%). No major complication occurred during or after the proce-
dure. Hospital discharge was at 2 days in the most of cases.
Conclusion Transcatheter closure method is a safe and effective alternative
to close PDA and to avoid surgical complications. The results of this proce-
dure depend of the operator experience.
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Traumatic induced VSD is a rare but serious disease because of the acute
hemodynamic changes. We reported one center experience in the interven-
tional catheterization closure of traumatic induced VSD during the last ten
years. We had 3 patients with four VSD. Mean age was 60 (40-71) years.
VSD was muscular secondary to external trauma in one patient, and to tran-
sapical transcatheter replacement of both of the aortic and mitral valves in the
second. Last patient had membranous and muscular VSD post Ross-Konno
intervention. All patients had acute congestive heart failure. All procedures
were performed under general anesthesia and transesophageal echocardio-
graphy control. Arteriovenous loop was always used to introduce the delivery
sheath to the left ventricle. VSDs diameter was evaluated by echography and
ranged from 9 to 13mm. Device diameter was chosen 1 to 2mm over the echo-
graphic measures. Multiple devices were used (Amplatzer® septal occluder,
Amplatzer® muscular VSD occluder, Occlutech® Figulla septal occluder).
Mean procedures time was 113 (100-145) min, and mean irradiation dose was
160 (103-203) Gycm2. Non significant residual shunt was observed in all
patients, but the heart failure was resolved in all. Complications were regis-
tered in three procedures: transient hemolytic anemia, severe bradycardia, tri-
cuspid cordage rupture and groin hematoma. 
